Bluejay Diagnostics, Inc. Finance Lease, Right-of-Use Asset, Amortization
Bluejay Diagnostics, Inc. (BJDX) reported Finance Lease, Right-of-Use Asset, Amortization of $80.66 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2023-08-14
- Bluejay Diagnostics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2023-06-30 was $40.33K, a 4.11% increase year-over-year.
- Bluejay Diagnostics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2023-03-31 was $40.33K, a 42.81% increase year-over-year.
- Bluejay Diagnostics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-06-30 was $38.73K.
- Bluejay Diagnostics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-03-31 was $28.24K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month |
|---|---|---|
| 2023-06-30 | $40.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $80.66K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $40.33K 10-Q · filed 2023-05-11 | |
| 2022-06-30 | $38.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $66.97K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $28.24K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |